摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-双(2-羟乙基)-2,5-二酮哌嗪 | 50975-79-6

中文名称
3,6-双(2-羟乙基)-2,5-二酮哌嗪
中文别名
——
英文名称
3,6-bis-(β-hydroxyethyl)-2,5-diketopiperazine
英文别名
3,6-di(2-hydroxyethyl)piperazine-2,5-dione;3,6-bis-(2-hydroxy-ethyl)-piperazine-2,5-dione;3,6-Bis-(2-hydroxy-aethyl)-piperazin-2,5-dion;D,L-3,6-Bis-(β-hydroxyethyl)-2,5-diketopiperazin;3,6-Bis-(β-hydroxyethyl)-2,5-diketo-piperazin;3,6-Bis(2-hydroxyethyl)-2,5-piperazinedione;3,6-bis(2-hydroxyethyl)piperazine-2,5-dione
3,6-双(2-羟乙基)-2,5-二酮哌嗪化学式
CAS
50975-79-6
化学式
C8H14N2O4
mdl
MFCD00278410
分子量
202.21
InChiKey
YCISBBFTTVKSNK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    188 °C
  • 沸点:
    340.32°C (rough estimate)
  • 密度:
    1.2845 (rough estimate)
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    -1.9
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    98.7
  • 氢给体数:
    4
  • 氢受体数:
    4

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2933599090
  • 储存条件:
    存放在阴凉干燥处即可。

SDS

SDS:e0624b51848a4bc6cc72b5897062d0b3
查看
Name: 3 6-Bis(2-Hydroxyethyl)-2 5-Diketopiperazine 98% Material Safety Data Sheet
Synonym: 3,6-Bis(2-Hydroxyethyl)-2,5-Piperazinedione
CAS: 50975-79-6
Section 1 - Chemical Product MSDS Name:3 6-Bis(2-Hydroxyethyl)-2 5-Diketopiperazine 98% Material Safety Data Sheet
Synonym:3,6-Bis(2-Hydroxyethyl)-2,5-Piperazinedione

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
50975-79-6 3,6-Bis(2-Hydroxyethyl)-2,5-Diketopipe 98% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. Use with adequate ventilation.
Storage:
Store in a cool, dry place. Keep container closed when not in use.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 50975-79-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 188.00 - 192.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H14N2O4
Molecular Weight: 202.21

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 50975-79-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,6-Bis(2-Hydroxyethyl)-2,5-Diketopiperazine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 50975-79-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 50975-79-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 50975-79-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Preparation of Methionine or Selenomethionine from Homoserine via a Lactone Intermediate
    申请人:Lorbert Stephen J.
    公开号:US20130006014A1
    公开(公告)日:2013-01-03
    Provided herein are processes for the production of methionine or selenomethionine from homoserine. In particular, the processes proceed via the production of lactone intermediates.
    本文提供了从高丝氨酸生产蛋氨酸或硒蛋氨酸的过程。特别是,该过程通过产生内酯中间体进行。
  • Method for production of methionine from homoserine
    申请人:Hateley Martin
    公开号:US20080146840A1
    公开(公告)日:2008-06-19
    The invention relates to a method for production of D- and/or L-methionine via D- and/or L-homoserine with subsequent chemical transformation to give methionine.
    该发明涉及一种通过D-和/或L-同型半胱氨酸进行生产D-和/或L-蛋氨酸的方法,并通过化学转化得到蛋氨酸的方法。
  • Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids
    申请人:THE DOW CHEMICAL COMPANY
    公开号:EP0471592A2
    公开(公告)日:1992-02-19
    Sulfur dioxide is removed from a fluid containing SO2 by employing as an absorbent for the SO2 an aqueous solution of a compound represented by Formulae I, II or III : wherein each Y is independently -(CR22)- or -(CR2)= ; each R1, R2, R5 or R6 is independently hydrogen, an alkyl group ; an hydroxyalkyl group ; an aldehyde group ; a carboxylic acid group or salt thereof ; or an alkyl group containing at least one carboxylic acid ester, a carboxylic acid or salt thereof, ether, aldehyde, ketone, or sulfoxide group ; wherein at least one of R1 and R2 and at least one of R5 and R6 is a carbonyl-containing group ; each R3 or R4 is independently hydrogen ; an alkyl group ; a hydroxyalkyl group ; an aldehyde group ; a carboxylic acid or salt group ; or an alkyl, aryl, or aralkyl group containing at least one carboxylic ester, a carboxylic acid or salt, ether, aldehyde, ketones or sulfoxide group. The absorbent solution preferably can be thermally regenerated by heating to remove SO2.
    通过使用由式 I、II 或 III 所代表的化合物的水溶液作为二氧化硫的吸收剂,从含有二氧化硫的流体中去除二氧化硫: 其中每个 Y 独立地为-(CR22)-或-(CR2)=;每个 R1、R2、R5 或 R6 独立地为氢、烷基、羟烷基、醛基、羧酸基或其盐、或含有至少一个羧酸酯、羧酸或其盐、醚、醛、酮或亚砜基的烷基;其中 R1 和 R2 中的至少一个以及 R5 和 R6 中的至少一个是含羰基的基团;每个 R3 或 R4 独立地是氢;烷基;羟烷基;醛基;羧酸或盐基;或含有至少一个羧酸酯、羧酸或盐、醚、醛、酮或亚砜基团的烷基、芳基或芳烷基。吸收剂溶液最好可以通过加热进行热再生,以去除二氧化硫。
  • Fischer,E.; Blumenthal, Chemische Berichte, 1907, vol. 40, p. 112
    作者:Fischer,E.、Blumenthal
    DOI:——
    日期:——
  • The Relationship between Homoserine and its Lactone
    作者:Marvin D. Armstrong
    DOI:10.1021/ja01178a037
    日期:1949.10
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物